Clinical Trials Browser

Phase 1 × Pancreatic Neoplasms × Lapatinib × Clear all

NCT00447122 2022-03-08

BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer

Phase 1 Terminated

25 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms